Skip Navigation LinksHome > December 2013 - Volume 2 - Issue 4 > Human and equine cardiovascular endocrinology: beware to co...
Text sizing:
A
A
A
Cardiovascular Endocrinology:
doi: 10.1097/XCE.0000000000000009
Review articles

Human and equine cardiovascular endocrinology: beware to compare.

Van Der Vekens, Nickya; Hunter, Ingridb; Goetze, Jens P.c; Decloedt, Anneliesa; De Clercq, Dominiquea; van Loon, Gunthera

Collapse Box

Abstract

Cardiac biomarkers such as troponins and natriuretic peptides are routinely used in human medicine for the evaluation of myocardial damage and heart failure. Recently, these markers have also been introduced in veterinary medicine. Comparison between human and equine cardiac biomarker studies show important species differences, which can partly be explained by variations in physiology or pathophysiology. Most important are physiological differences in heart rate, cardiovascular response to exercise, food and water intake, and molecular elimination in plasma. Pathological differences are even more prominent. In humans, troponins and natriuretic peptides are mostly used for the diagnosis of acute coronary syndromes and heart failure. These cardiac entities, however, are rare in horses. In this species, cardiac biomarkers are rather proposed for the assessment of valvular or myocardial disease. In conclusion, these species differences corroborate that extrapolation of cardiac biomarker data should always be performed with caution and species-specific data should be applied whenever possible.

© 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

You currently do not have access to this article.

You may need to:

Note: If your society membership provides for full-access to this article, you may need to login on your society’s web site first.

Login

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.